Gonadorelin Formulation

Hazard statements (CLP)

H317, H361fd, H372

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

Classification of the substance or mixture Skin sensitisation Category 1 Reproductive toxicity Category 2 Specific target organ toxicity - repeated exposure (Oral) Category 1 (Endocrine system)

Signal word

Danger

Hazard statements

H317 May cause an allergic skin reaction. H361fd Suspected of damaging fertility. Suspected of damag- ing the unborn child. H372 Causes damage to organs (Endocrine system) through prolonged or repeated exposure if swallowed.

Prevention

P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe mist or vapours. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection/ hearing protection.

Response

P302 + P352 IF ON SKIN: Wash with plenty of water. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P333 + P313 If skin irritation or rash occurs: Get medical ad- vice/ attention. P362 + P364 Take off contaminated clothing and wash it before reuse.

Storage

P405 Store locked up.

Disposal

P501 Dispose of contents/ container to an approved waste disposal plant.

Other hazards which do not result in classification

None known.

2.1 Classification of the substance or mixture

Skin sensitisation : Category 1 Reproductive toxicity : Category 2 Specific target organ toxicity - : Category 1 (Endocrine system) repeated exposure (Oral)